Report Company Directory

Histogen Inc

• Histogen Files for Voluntary Chapter 11 Protection to Facilitate Wind-Down, Maximize Share Offering by GlobeNewsWire
• Histogen Announces Second Adjournment of Special Meeting of Stockholders by GlobeNewsWire
• Histogen Announces Adjournment of Special Meeting of Stockholders by GlobeNewsWire
• Histogen Announces Board Approval of Complete Liquidation and Dissolution by GlobeNewsWire
• Histogen to Explore Strategic Alternatives by GlobeNewsWire
• Histogen Reports First Quarter 2023 Results and Provides Business Update by GlobeNewsWire
• Histogen Announces Online Publication in the Journal of Investigative Dermatology by GlobeNewsWire
• Histogen Announces Exclusive Intellectual Property License Agreement with Johns Hopkins University by GlobeNewsWire
• Histogen Announces Issuance of US Patent Covering CTS-2090 Methods of Use by GlobeNewsWire
• Histogen Reports Year-End 2022 Results and Provides Business Update by GlobeNewsWire

HISTOGENICS CORP

• Histogenics Corporation Announces Approval of Merger by Stockholders at Special Meeting by GlobeNewsWire
• Histogenics Corporation Announces Adjournment of its Special Meeting to Thursday, September 26, 2019 by GlobeNewsWire
• Histogenics Corporation Announces Intent to Convene and Adjourn Its Special Meeting by GlobeNewsWire
• Histogenics and Ocugen Enter into Definitive Merger Agreement to Create Nasdaq-Listed Clinical-Stage Company Developing Novel Ocular Gene Therapies and Biotherapeutics by GlobeNewsWire
• InsiderInsights Weekly Tables: March 1, 2019 by InsiderInsights.com
• InsiderInsights Weekly Tables: February 2, 2019 by InsiderInsights.com
• InsiderInsights Daily Ratings Report: January 15, 2019 by InsiderInsights.com
• Histogenics and FDA Conclude Discussions Regarding NeoCart® Phase 3 Clinical Trial Data and Regulatory Pathway by GlobeNewsWire
• Histogenics and FDA Continue to Discuss NeoCart® Phase 3 Clinical Trial Data and Potential Regulatory Pathway by GlobeNewsWire
• Histogenics Corporation Announces Third Quarter 2018 Financial and Operating Results by GlobeNewsWire

HIT CO. LTD.

HIT KIT GLOBAL SOLUTIONS LTD

HIT Shouchuang Technology (A)

• Ford Equity International Rating and Forecast Report by Ford Equity Research